Multimeric Anti-DR5 IgM antibody displays potent cytotoxicity in vitro and promotes tumor regression in vivo Posted on April 25, 2017August 2, 2018 by IGM Continue reading→
High Avidity Anti-CD20 IgM Antibody for Enhanced Complement-Dependent Cell Killing of Low CD20 Expressing Tumor Cells Posted on April 25, 2016August 2, 2018 by IGM Continue reading→
IGM-55.5, a novel monoclonal human recombinant IgM antibody with potent activity against B cell leukemia and lymphoma Posted on April 25, 2014August 2, 2018 by IGM Continue reading→